ID28280A - BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2 - Google Patents

BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2

Info

Publication number
ID28280A
ID28280A IDW20010781A ID20010781A ID28280A ID 28280 A ID28280 A ID 28280A ID W20010781 A IDW20010781 A ID W20010781A ID 20010781 A ID20010781 A ID 20010781A ID 28280 A ID28280 A ID 28280A
Authority
ID
Indonesia
Prior art keywords
benzotienol
antagonists
pyridine
Prior art date
Application number
IDW20010781A
Other languages
English (en)
Indonesian (id)
Inventor
L E J Kennis
S M A Pieters
F P Bischoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28280A publication Critical patent/ID28280A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20010781A 1998-10-06 1999-10-01 BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2 ID28280A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06

Publications (1)

Publication Number Publication Date
ID28280A true ID28280A (id) 2001-05-10

Family

ID=8234188

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010781A ID28280A (id) 1998-10-06 1999-10-01 BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2

Country Status (28)

Country Link
US (2) US6426350B1 (xx)
EP (1) EP1117667B1 (xx)
JP (1) JP4580555B2 (xx)
KR (1) KR20010071828A (xx)
CN (1) CN1158287C (xx)
AR (1) AR023678A1 (xx)
AT (1) ATE363485T1 (xx)
AU (1) AU760226B2 (xx)
BG (1) BG64625B1 (xx)
BR (1) BR9913110A (xx)
CA (1) CA2346084C (xx)
CZ (1) CZ20011103A3 (xx)
DE (1) DE69936219T2 (xx)
EE (1) EE04835B1 (xx)
ES (1) ES2288025T3 (xx)
HK (1) HK1039113A1 (xx)
HU (1) HUP0103612A3 (xx)
ID (1) ID28280A (xx)
IL (2) IL142442A0 (xx)
NO (1) NO20011309L (xx)
NZ (1) NZ509911A (xx)
PL (1) PL347184A1 (xx)
RU (1) RU2222542C2 (xx)
SK (1) SK4312001A3 (xx)
TR (1) TR200100954T2 (xx)
TW (1) TWI251595B (xx)
UA (1) UA70334C2 (xx)
WO (1) WO2000020422A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494000T1 (de) * 2002-03-08 2011-01-15 Max Planck Gesellschaft Verwendung von egfr transaktivierungsinhibitoren für menschlichen krebs
WO2003082825A1 (en) * 2002-04-03 2003-10-09 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd CYCLIC AMINE COMPOUND

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
JPH0256485A (ja) * 1988-04-27 1990-02-26 Glaxo Group Ltd ラクタム誘導体
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
JP4580555B2 (ja) 2010-11-17
US6426350B1 (en) 2002-07-30
EP1117667B1 (en) 2007-05-30
DE69936219T2 (de) 2008-02-07
JP2002526546A (ja) 2002-08-20
NZ509911A (en) 2002-09-27
NO20011309D0 (no) 2001-03-15
NO20011309L (no) 2001-03-15
KR20010071828A (ko) 2001-07-31
BG105331A (en) 2001-11-30
HUP0103612A2 (hu) 2002-01-28
EP1117667A1 (en) 2001-07-25
TWI251595B (en) 2006-03-21
EE04835B1 (et) 2007-06-15
IL142442A0 (en) 2002-03-10
US20020169178A1 (en) 2002-11-14
AR023678A1 (es) 2002-09-04
ATE363485T1 (de) 2007-06-15
CN1321159A (zh) 2001-11-07
TR200100954T2 (tr) 2001-12-21
EE200100206A (et) 2002-06-17
CN1158287C (zh) 2004-07-21
HK1039113A1 (en) 2002-04-12
UA70334C2 (en) 2004-10-15
WO2000020422A1 (en) 2000-04-13
ES2288025T3 (es) 2007-12-16
CZ20011103A3 (cs) 2001-12-12
CA2346084A1 (en) 2000-04-13
HUP0103612A3 (en) 2003-03-28
SK4312001A3 (en) 2001-12-03
US6774129B2 (en) 2004-08-10
CA2346084C (en) 2010-01-26
BG64625B1 (bg) 2005-09-30
DE69936219D1 (de) 2007-07-12
RU2222542C2 (ru) 2004-01-27
BR9913110A (pt) 2001-05-08
AU760226B2 (en) 2003-05-08
PL347184A1 (en) 2002-03-25
AU6089999A (en) 2000-04-26
IL142442A (en) 2006-10-05

Similar Documents

Publication Publication Date Title
CU23053A3 (es) 1,2,3,4-tetrahidroquinlinas 2-sustituidas 4-amino sustituidas
ID18003A (id) Antagonis muskarinik
DE69907964D1 (de) 1,2-annelierte chinolinderivate
PT1087971E (pt) Compostos de pirrolo[2,3-d]piridina
ATE312819T1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor- wirkung
ID19623A (id) Antagonis reseptor vitronektin
IL157873A0 (en) DIHYDRO-BENZO [b] [1,4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
ID26698A (id) SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
IS5815A (is) Setin 1,8-naftýridín-4(1H)-ón sem fosfódíesterasa4 latar
PL367086A1 (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i
ID26223A (id) Antagonis reseptor vitronektin
ID26665A (id) Antagonis vla-4
NO990859D0 (no) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID28811A (id) Antagonis reseptor vitronektin
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID30484A (id) Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin
NO20004807L (no) 3´,3´-N-bis-substituerte makrolid LHRH antagonister
ID28280A (id) BENZOTIENOL [3,2-C] PIRIDIN SEBAGAI ANTAGONIS α2
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
PT1010699E (pt) Derivados de 3-oxadiazolil-1,6-naftiridina-2(h)-ona substituido em 5
DE69714019D1 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten
EE200200267A (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiinid ja nende kasutamine ravimina